Jason Wachub
π€ SpeakerAppearances Over Time
Podcast Appearances
What he found changed how he operates, and I think it'll change how you think about performance too.
Let's dive in.
So testing has come such a long way in the past few years with regards to our cognitive health.
And, you know, we can do genetic testing and look, do we have the APOE4 gene?
Do we have a double copy of the gene?
We can do the blood markers, you know, P-tau.
amyloid.
And it's fascinating and interesting.
And I'm a believer that information is power and early intervention can be extraordinarily helpful and lifesaving.
But the more I learn as it relates to cognitive decline and what we know about dementia and Alzheimer's,
I kind of feel like we look at these things because they're measurable, but they may not be the most important drivers.
MARK BLYTH, JR.
: So in other words, testing p tau in a vacuum is not necessarily helpful.
MARK BLYTH, JR.
: Exactly.
Yeah.
MARK BLYTH, JR.
: And so what do we know for sure in 2026?
So I love the book.
I encourage everyone to get it.